Article

Safeguarding COVID-19 and cancer management: drug design and therapeutic approach

2021-07-05

Abstract excerpt

Recent clinical cohort studies have highlighted that there is a three-fold greater SARS-Cov-2 infection risk in cancer patients, and overall mortality in individuals with tumours is increased by 41% with respect to general COVID-19 patients. Thus, access to therapeutics and intensive care is compromised for people with both diseases (comorbidity) and there is risk of delayed access to diagnosis. This comorbidity h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9b318833-2f70-5b31-9fe4-18971ccc102f
DOI: 10.12688/openreseurope.13841.1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Safeguarding COVID-19 and cancer management: drug design and therapeutic approachDOI 10.12688/openreseurope.13841.1Read

Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer PatientsSemantic proximity Read

Characteristics and outcome of SARS-CoV-2 infection in cancer patients.Semantic proximity Read

SARS-CoV-2 infection as a potential risk factor for the development of cancerSemantic proximity Read

Cancer inpatient with COVID-19: a report from the Brazilian National Cancer InstituteSemantic proximity Read

Recognition of plausible therapeutic agents to combat COVID-19: An omics data based combined approachSemantic proximity Read

A systematic review and meta-analysis of cancer patients affected by a novel coronavirusSemantic proximity Read

The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with CancerSemantic proximity Read

COVID-19 and Cancer: A Comparative Case SeriesSemantic proximity Read

Cancer and the Risk of COVID-19 Diagnosis, Hospitalisation, and Death: A Population-Based Multi-State Cohort Study Including 4,618,377 Adults in Catalonia, SpainSemantic proximity Read

Drug-repurposing against COVID-19 by targeting a key signaling pathway: An in silico studySemantic proximity Read

COVID-19 and Malignancy: Exploration of the possible genetic and epigenetic interlinks and overview of the vaccination scenario.Semantic proximity Read

Covid-19 And Cancer: Insights Into Their Association And Influence On Genetic And Epigenetic LandscapeSemantic proximity Read